Karen Midthun, MD (SCHAGY), Director, Center for Biologics Evaluation and Research, FDA, United States
Previously served as the Deputy Dir of CBER and Dir, Off of Vaccines Rsrch and Review. She was on the faculty of the Dept of Intl Health at Johns Hopkins Bloomberg Sch of Public Health, involved in the clinical development of investigational vaccines and an attending physician at the hospital.
SPEAKER
:
Robert A. Yetter, PhD (SPKAGY), Associate Director for Review Management, Office of the Director, CBER, FDA, United States
ROBERT A. YETTER is the Associate Director for Review Management, CBER, FDA. He received a B.S. from Emory University, M.S. from Georgia State University and Ph.D. from the University of Florida. Prior to joining CBER, he spent six years at NIAID and four years in the Research Service DVA.
Description
This forum was moved from 2:30 PM to 11:00 AM as of April 24, 2013
This forum will provide an overview of CBER's current work on ongoing initiatives, guidances, and regulations.